cardiac arrest - Meadowbrook Care Center

FDA Expands TAVR Indication to Low-Risk Patients

By Meadowbrook Staff | August 21, 2019 |

Hot off the Press…The U.S. Food and Drug Administration (FDA) approves an expanded indication for several transcatheter heart valves (Sapien 3, Sapien 3 Ultra, CoreValve Evolut R and CoreValve Evolut PRO) to include patients with severe aortic valve stenosis at low surgical risk. According to the FDA, the incidence of aortic valve stenosis increases with age.…

Better Science Needed to Identify clinical predictors that link cardiac arrest, brain injury, and death

By Meadowbrook Staff | July 11, 2019 |

The American Heart Association (AHA) releases a statement July 11 calling for better science to support clinical predictors that link cardiac arrest, brain injury and the patient’s death. The new research findings published in the AHA’s journal Circulation note that resuscitation and post-resuscitation care after cardiac arrest have both improved but mortality remains high Inaccurate Neurologic…